openPR Logo
Press release

ENT Disorder Treatment Market - Size, Share, Growth and Trends Analysis 2018–2026

06-26-2018 03:15 PM CET | Health & Medicine

Press release from: CMI - Market Research

ENT Disorder Treatment Market - Size, Share, Growth and Trends

The Global ENT Disorder Treatment Market, by Organ Type (Ear, Nose, and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 9,521.1 million in 2016 and is projected to exhibit a CAGR of 3.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. The ENT Disorders treatment market is expected to gain significant traction with increasing incidence of ENT disorders and increasing environmental pollution globally. According to an article published by Harvard Medical School and Teaching Hospital, 2017, over 360 million people across the globe are suffering from hearing loss and over half of this population can be treated with proper medication and care.

Browse Full Report: https://www.coherentmarketinsights.com/market-insight/ent-disorder-treatment-market-1326

Development novel treatments for ENT disorders through extensive R&D is expected to be a major factor driving the global ENT disorder treatment market growth

Manufacturers are focusing on development new and innovative treatments and therapies for ENT disorders for both adult and pediatric segments, in order to maintain their market share. For instance, Otonomy, Inc. — a U.S. based drug manufacturer — received FDA approval for OTIPRIO (ciproflaxin otic suspension) in December 2015, for treatment of pediatric patients suffering with bilateral otitis media with effusion. In May 2012, Meda Pharmaceuticals received FDA approval for dymista (azelastine hydrochloride and fluticasone propionate) for the treatment of seasonal allergic rhinitis that can be consumed by intranasal administration or sprayed suspension. Furthermore, in June 2017, Inspire Medical Systems received FDA approval for Inspire 3028 neurostimulator for the treatment of obstructive sleep apnea.

Browse 42 Market Data Tables and 36 Figures spread through 161 Pages and in-depth TOC on “Global ENT Disorder Treatment Market”- by Treatment Type (Devices (Hearing Aid Devices, Voice Prosthesis, Nasal Splints, Hearing Implants and Others) and Drug Type(Antibiotics, Antihistamines, Steroids, Anti-inflammatory Drugs, Others)), By Organ Type (Ear, Nose and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

Key players are focusing on strategic merger and acquisition strategies for development and commercialization of novel ENT therapeutics and medical devices. For instance, December 2017, Entellus Medical, Inc. — a leader in ENT drugs segment — entered a definitive merger agreement with Stryker Corporation for development of effective ENT solutions through collaboration. Moreover, in in July 2017, Entellus Medical acquired Spirox, Inc. a privately held company that manufactures, develops and markets ENT medical devices.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1326

Key Takeaways of the ENT Disorder Treatment Market:

The global ENT disorder treatment market is expected to exhibit a CAGR of 3.22% over the forecast period, owing to rising incidence of ENT disorders coupled with deteriorating environmental factors such as rising air and noise pollution across the globe. For instance, according to CDC 2016, 30 million people in the U.S. were exposed to extremely high decibels sound levels, at workplace, leading to hearing disorders.

Among treatment type segment, drug segment holds a dominant position in the global ENT disorder treatment market. This is owing to drug being the first line of treatment in most of the ENT disorders.

Among end users, hospital segment holds a dominant position in the global ENT disorder treatment market, as most of the surgical, non-surgical as well as consultation procedures are conducted at hospitals.

Some of the major players operating in the global ENT disorder treatment market include Sanofi, AstraZeneca plc, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddys Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1326

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ENT Disorder Treatment Market - Size, Share, Growth and Trends Analysis 2018–2026 here

News-ID: 1098714 • Views:

More Releases from CMI - Market Research

Dental Braces Market - Industry Insights, Size, Share, Growth, Analysis, Trends and Forecasts To 2026
Dental Braces Market - Industry Insights, Size, Share, Growth, Analysis, Trends …
Dental braces are commonly used in orthodontic treatment to improve an individual’s orofacial appearance. Malocclusions (tooth overcrowding or crooked teeth), overbites, deep bites, cross bites, under bites, and incorrect jaw positions are some of the conditions that affect the orofacial appearance and other orthodontic problems. Malocclusions often lead to lack of confidence in a person. Increasing number of cases of malocclusions, jaw disease, jaw pain, tooth decay, and tooth loss
Colon and Rectal Cancer Drugs Market – Industry Size, Growth, outlook and Analysis, 2018–2026
Colon and Rectal Cancer Drugs Market – Industry Size, Growth, outlook and Anal …
Colon and rectal cancer are often grouped together, as they have many common features. Rate of colorectal cancer is increasing among the millennials in the U.S. The American Cancer Society (ACS) estimates that there will be around 97,220 new cases of colon cancer and around 43,030 new cases of rectal cancer registered in the U.S. in 2018. Moreover, owing to increasing risk of colorectal cancer, in May 2018, ACS updated
Clostridium Difficile Infection Treatment Market Growth, Size, Trends and Analysis, 2018-2026
Clostridium Difficile Infection Treatment Market Growth, Size, Trends and Analys …
Clostridium difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinical manifestation ranging from asymptomatic infection to watery diarrhea or serious intestinal condition such as colitis and colonic perforation. This infection can be diagnosed by enzyme immunoassays for toxins or Clostridium difficile glutamate dehydrogenase (GDH) and nucleic
Cervical Cancer Drugs Market - Size, Share, Growth | Trend and Analysis, 2018-2026
Cervical Cancer Drugs Market - Size, Share, Growth | Trend and Analysis, 2018-20 …
Cervical cancer develops in women’s cervix, and mainly affects sexually active women aged between 30 and 45. Cervical cancer often shows no symptoms in early stages. However, the death rate of cervical cancer can be significantly reduced with use of Pap test (Papanicolaou test): a screening procedure which can detect the changes in the cervix before the cancer develops. There are different types of cervical cancer, out of which two

All 5 Releases


More Releases for ENT

07-21-2021 | Health & Medicine
Fact.MR
Which Product Type Will be Highly Utilized by ENT Surgeons in the ENT Surgical D …
ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to, • Technological advancements enhancing ENT procedure efficiency and outcome For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=2454&utm_source=openpr&utm_medium=Prasad • Reimbursement policies
ENT Diagnostic Devices Market Facts, Figures and Analytical Insights, 2018 to 20 …
ENT diagnostic devices market is estimated to hit US$ 2.3 billion in 2019, according to a new study by Fact.MR. The market grew at 6.3% y-o-y in 2018 with bronchoscopes accounting for nearly one third of the global revenues. Overall growth of the ENT diagnostic devices market can be attributed to, Advanced technology incorporations in ENT diagnostic devices Favorable reimbursement policies for ENT procedures Development of efficient and low-priced devices According to Fact.MR study,
ENT Workstation Market Segmentation By product type Fixed ENT Workstation, Porta …
The diagnosis and treatment of diseases occurring in upper air passages and ENT organs require thorough attention. The growing need for the usage of qualitative modern equipment to perform ENT procedures as well as the need for improved accessibility of doctor’s instruments to inspect a large patient pool plays a fundamental role in driving the demand for ENT workstations in the market. The usage of ENT workstations in ENT clinics
United States ENT Endoscopes Market Report
In this report, the United States ENT Endoscopes market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Global ENT MICROSCOPES Market Intelligence Report for Comprehensive Information …
Description: Orbis Research always aims to bring their clients the best research material and in-depth analysis of the information for any market. This new report Global ENT Microscopes Sales Market for 2018 aims to fulfil the needs of the clients looking for a fresh outlook towards the Global ENT Microscopes Sales Market, or fill in the knowledge gaps with the data available in the report. The well-presented and curated report is
2017 ENT Devices Market Embraces Advancements
In this report, the global ENT Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ENT Devices in these regions, from 2012 to 2022 (forecast), covering North